1,000
Participants
Start Date
September 30, 2006
Study Completion Date
December 31, 2008
MPC-7869
800 mg BID Oral dosing
Alabaster
Huntsville
Phoenix
Sun City
Tucson
Costa Mesa
Irvine
Lafayette
Laguna Hills
Long Beach
Rancho Mirage
Sacramento
San Diego
San Francisco
Vista
Danbury
Darien
New Haven
Washington D.C.
Deerfield Beach
Fort Meyers
Fort Myers
Hollywood
Jacksonville
Miami
Naples
Sunrise
Tampa
West Palm Beach
Atlanta
Chicago
Fort Wayne
Indianapolis
Lexington
Baltimore
Glen Burnie
Boston
West Yarmouth
Ann Arbor
Grand Rapids
Rochester
St Louis
Lebanon
Kenilworth
Morristown
Princeton
Stratford
Albuquerque
Albany
Brooklyn
Elmsford
New York
Olean
Rochester
Syracuse
Durham
Raleigh
Centerville
Columbus
Toledo
Oklahoma City
Eugene
Portland
Jenkintown
Philadelphia
Pittsburgh
Scotland
East Providence
Beaufort
Charleston
Greer
Memphis
Nashville
Dallas
Houston
San Antonio
Ogden
Salt Lake City
Bennington
Alexandria
Charlottesville
Virginia Beach
Middleton
Milwaukee
Winnepeg
Halifax
Kingston
Ottawa
Toronto
Regina
Lead Sponsor
Myrexis Inc.
INDUSTRY